Two pink pills and one white pill taken twice a day for five days reduce the risk of hospitalization and death in the most vulnerable Covid patients by almost 90%. The effectiveness of Paxlovid, shown in clinical trials, has been confirmed by several studies since its approval in January 2022. But this antiviral drug is rarely used. in the most recent wave, last winter, it was delivered to fewer than 55,000 patients. Another curative treatment, Remdesivir, can also be offered to people at risk of severe Covid, but it must be administered intravenously under strict medical supervision. “ We are seeing far too many hospitalizations for Covid-19 that could have been avoided with available treatments »comments Antoine Flao, an epidemiologist and professor of public health at the University of Geneva.
Five days after the first symptoms
The still rare use of Paxlovid (a combination of nirmatrelvir…
Source: Le Figaro
I am John Sinkler, a professional writer and journalist for Buna Times. I specialize in writing about entertainment-related topics and have been doing so for several years now. My work has been featured on multiple platforms and I’m proud to say that it’s gained recognition from many people in the industry. Aside from working at Buna Times, I also write freelance articles for other publications.